Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Jun 26;189(25):E869.
doi: 10.1503/cmaj.733099.

Identifying those infected with hepatitis C virus

Eric M Yoshida  1 , Eberhard Renner  2 , Philip Wong  3 , Mel Krajden  4
Affiliations
Comment

Identifying those infected with hepatitis C virus

Eric M Yoshida et al. CMAJ. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: Eric Yoshida has received research grants from Merck, Gilead Sciences, Janssen and AbbVie. He has also received lecture fees from Merck Canada, Gilead Sciences Canada and AbbVie Canada. Eberhard Renner has participated in advisory boards and has received consultant or speaker fees from AbbVie, Astellas, Bristol-Myers Squibb, Gilead Sciences, Janssen, Lupin, Merck and Novartis. He has also received research support from Gilead Sciences, Novartis and Roche. Philip Wong has received consultant and speaker fees from Astellas, Gilead Sciences, Lupin and Novartis. Mel Krajeden has received research grants or contracts paid to his institution from Roche, Merck, Hologic, Siemens and Boehringer Ingelheim.

Comment on

  • Recommendations on hepatitis C screening for adults.
    Grad R, Thombs BD, Tonelli M, Bacchus M, Birtwhistle R, Klarenbach S, Singh H, Dorais V, Holmes NM, Martin WK, Rodin R, Jaramillo Garcia A; Canadian Task Force on Preventive Health Care. Grad R, et al. CMAJ. 2017 Apr 24;189(16):E594-E604. doi: 10.1503/cmaj.161521. CMAJ. 2017. PMID: 28438952 Free PMC article. No abstract available.

References

    1. Canadian Task Force on Preventive Health Care. Recommendations on hepatitis C screening for adults. CMAJ 2017;189:E594–604. - PMC - PubMed
    1. Trubnikov M, Yan P, Archibald C. Estimated prevalence of hepatitis C virus infection in Canada, 2011. Can Commun Dis Rep 2014;40–19:429. - PMC - PubMed
    1. HBV and HCV infection awareness among those with laboratory-confirmed hepatitis, by type of hepatitis, household population aged 14 to 79, Canada, 2007 to 2011 [table]. Ottawa: Statistics Canada; 2015. Available: www.statcan.gc.ca/pub/82-003-x/2013011/article/11876/tbl/tbl5-eng.htm (accessed 2017 Apr. 21).
    1. Shah HA, Heathcote J, Feld JJ. A Canadian screening program for hepatitis C: Is now the time? CMAJ 2013;185:1325–8. - PMC - PubMed
    1. Wong WWL, Tu H-A, Feld JJ, et al. Cost-effectiveness of screening for hepatitis C in Canada. CMAJ 2015;187:E110–21. - PMC - PubMed